New Chief Executive at Lloyds TSB Foundation
Linda Kelly is to succeed Kathleen Duncan as Chief Executive of the Lloyds TSB Foundation for England and Wales from 1 January 2006.
Linda has been Chief Executive of the Parkinson’s Disease Society (PDS) since July 2001, overseeing 300 branches supported by 4,500 volunteers and 220 staff and a fundraising income of over £15 million last year. Her career spans 25 years in the Healthcare Industry, with the last ten years in Director and leadership positions that culminated in the role of President UK of Astra Pharmaceuticals Limited (now part of Astra Zeneca).
With an income of £22.5 million in 2005, the independent Lloyds TSB Foundation for England and Wales gives grants to underfunded charities that work to improve the lives of people in local communities, especially those who are disadvantaged or disabled. The four Lloyds TSB Foundations, which also include Scotland, Northern Ireland and the Channel Islands, are one of the UK’s largest grant-making trusts and receive 1% of pre-tax profits from the Lloyds TSB Group averaged over three years, in lieu of shareholder dividend.
Advertisement
Kathleen Duncan has led the Foundation over the past fifteen years and help secured its reputation for innovation, lightness of touch, partnership work and core funding.